Catalysis, S.L.
Catalysis, S.L. is a Spanish biotechnology and pharmaceutical company specializing in human health, animal health, plant health, and pet health solutions. Headquartered in Madrid, Spain, the company has been at the forefront of scientific research and innovation in the development of nutritional supplements, therapeutic treatments, and biostimulants. With a strong focus on natural formulations, Catalysis has expanded its market presence across Europe, Latin America, and Asia.
Core Business
Catalysis, S.L. is dedicated to biotechnological research aimed at improving health and well-being through antioxidants, immunomodulators, and plant-based compounds. The company employs patented molecular activation technology to enhance the efficacy of its products, ensuring higher bioavailability and effectiveness.
Product and Service Offerings
Human Health Solutions
- Oncology Support – Supplements aimed at improving patient resilience during cancer treatments.
- Virology & Immunology – Antiviral and immune-boosting formulations for enhanced disease resistance.
- Chronic Disease Management – Products addressing inflammatory and metabolic conditions.
Animal Health Solutions
- Livestock Supplements – Formulations to enhance productivity and disease resistance.
- Companion Animal Products – Veterinary-approved supplements for pet health.
- Aquaculture Health – Solutions improving fish and shrimp farming productivity.
Plant Health Solutions
- Agricultural Biostimulants – Enhancing crop resilience and yield using plant-based formulations.
Pet Health Solutions
- Nutritional Supplements for Pets – Focused on joint health, immunity, and digestion.
Specialization and Unique Selling Points
- Molecular Activation Technology – A patented process increasing the bioavailability and potency of active ingredients.
- Research-Driven Innovation – Over 100+ clinical and scientific studies supporting product efficacy.
- Eco-Friendly and Sustainable Formulations – All products are naturally derived and free from harmful chemicals.
- Global Regulatory Compliance – Meeting EU, FDA, and WHO-GMP pharmaceutical standards.
- Multi-Sector Expertise – Comprehensive product offerings in human, animal, and plant health.
Financial Performance and Market Presence
- Annual Revenue: Over €20 million, with consistent growth in Europe, Latin America, and Asia.
- Market Share: A leading position in the nutraceutical and biopharmaceutical sectors.
- International Expansion: Products sold in over 50 countries, with 40% of revenue from exports.
Export and Shipment Data
- Over 10 million units of Catalysis products shipped worldwide annually.
- Key export markets include Spain, Mexico, Brazil, India, Vietnam, and the UAE.
- Distribution through 100+ international distributors and pharmaceutical partners.
Certifications and Compliance
- ISO 9001 Certified – Ensuring high-quality manufacturing and production standards.
- WHO-GMP Compliance – Following global pharmaceutical safety and efficacy guidelines.
- European Union Health Compliance – Approved for use across EU markets.
- EcoCert Certification – Recognized for environmentally sustainable product formulations.
Customer Testimonials
"Viusid has been an essential supplement in improving patient immunity and recovery rates in viral infections." – Oncologist, Spain
"Our livestock health has significantly improved with Catalysis supplements, leading to higher productivity and disease resistance." – Livestock Farm Owner, Brazil
Major Achievements
- 2023 Biotechnology Innovation Award for molecular activation technology.
- Recognized as a Top 5 Nutraceutical Exporter from Spain.
- Developed 50+ patented formulations in human and animal health sectors.
- Expanded distribution partnerships in North America, South America, and Southeast Asia.
Catalysis, S.L. continues to be a pioneer in biotechnological advancements, delivering high-quality, research-backed health solutions to improve the well-being of humans, animals, and plants worldwide.
